Verition Fund Management LLC lessened its holdings in shares of Afya Limited (NASDAQ:AFYA - Free Report) by 79.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 17,105 shares of the company's stock after selling 64,403 shares during the quarter. Verition Fund Management LLC's holdings in Afya were worth $292,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in AFYA. Quantbot Technologies LP grew its holdings in shares of Afya by 73.8% in the 3rd quarter. Quantbot Technologies LP now owns 13,268 shares of the company's stock valued at $226,000 after acquiring an additional 5,636 shares in the last quarter. Lifestyle Asset Management Inc. grew its holdings in shares of Afya by 13.3% in the 3rd quarter. Lifestyle Asset Management Inc. now owns 16,753 shares of the company's stock valued at $286,000 after acquiring an additional 1,969 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new position in shares of Afya in the 3rd quarter valued at about $417,000. Cubist Systematic Strategies LLC grew its holdings in shares of Afya by 136.9% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 35,254 shares of the company's stock valued at $622,000 after acquiring an additional 20,370 shares in the last quarter. Finally, Millennium Management LLC grew its holdings in shares of Afya by 45.0% in the 2nd quarter. Millennium Management LLC now owns 291,164 shares of the company's stock valued at $5,139,000 after acquiring an additional 90,383 shares in the last quarter. Institutional investors and hedge funds own 88.02% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on AFYA shares. UBS Group started coverage on Afya in a report on Friday, August 30th. They set a "neutral" rating and a $19.50 price target for the company. The Goldman Sachs Group started coverage on Afya in a report on Tuesday, December 3rd. They set a "sell" rating and a $16.00 price target for the company.
Read Our Latest Report on Afya
Afya Trading Down 0.2 %
NASDAQ AFYA traded down $0.03 on Friday, reaching $15.64. The company had a trading volume of 129,259 shares, compared to its average volume of 131,528. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.60 and a quick ratio of 1.60. The business has a 50 day moving average of $16.65 and a two-hundred day moving average of $16.97. Afya Limited has a fifty-two week low of $15.28 and a fifty-two week high of $22.48. The firm has a market cap of $1.47 billion, a price-to-earnings ratio of 12.61, a P/E/G ratio of 0.33 and a beta of 0.89.
About Afya
(
Free Report)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Stories
Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.